![5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide in PDB entry 6t32, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/6t32_entity_2_side_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>6t32</span> contains 4 copies of <span class='highlight'>5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide</span>. Side view.")
![5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide in PDB entry 6t32, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/6t32_entity_2_top_image-200x200.png "Homo tetrameric assembly 1 of PDB entry <span class='highlight'>6t32</span> contains 4 copies of <span class='highlight'>5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide</span>. Top view.")
Environment details NEW
HL9 201 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.